Merck & Co Inc
MRK
Company Profile
Business description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Contact
126 East Lincoln Avenue
Rahway NJ 07065
USAT: +1 908 740-4000
E: investor_relations@merck.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
72,000
Merck & Co Inc News & Analysis
stocks
What did Morningstar subscribers buy and sell during earnings season?
And what do our analysts think of the stocks and ETF?
personal-finance
5 investing rules I break in my portfolio
Don’t let perfect investing be the enemy of good
stocks
The ultimate buy and hold portfolio
Would stashing away 1986′s stock-market leaders have been a sound investment strategy?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,150.10 | 129.20 | 1.61% |
| CAC 40 | 8,188.49 | 51.50 | -0.63% |
| DAX 40 | 18,738.81 | 130.55 | -0.69% |
| Dow JONES (US) | 39,914.19 | 6.19 | 0.02% |
| FTSE 100 | 8,438.65 | 7.15 | -0.08% |
| HKSE | 19,376.53 | 302.82 | 1.59% |
| NASDAQ | 16,728.21 | 14.18 | -0.08% |
| Nikkei 225 | 38,920.26 | 534.53 | 1.39% |
| NZX 50 Index | 11,728.06 | 202.18 | 1.75% |
| S&P 500 | 5,306.40 | 1.75 | -0.03% |
| S&P/ASX 200 | 7,881.30 | 127.60 | 1.65% |
| SSE Composite Index | 3,122.40 | 2.50 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.13% |
| Telstra Group Ltd TLS | 3.69 | 0.02 | 0.55% |
| South32 Ltd S32 | 3.75 | 0.08 | 2.18% |
| PYC Therapeutics Ltd PYC | 0.10 | 0.01 | -7.62% |
| Pilbara Minerals Ltd PLS | 4.01 | 0.03 | 0.75% |
| Incitec Pivot Ltd IPL | 2.97 | 0.15 | 5.32% |
| Red 5 Ltd RED | 0.49 | 0.02 | 4.26% |
| Pantoro Ltd PNR | 0.09 | 0.01 | 7.41% |
| Vicinity Centres VCX | 1.98 | 0.05 | 2.60% |
| Mirvac Group MGR | 2.15 | 0.06 | 2.87% |